Cita APA

Tang, Q., Lei, H., Wu, H., Chen, J., Deng, C., Sheng, W., . . . Zhong, S. (2018). Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy. Acta Pharmacol Sin.

Chicago Style Citation

Tang, Qian-jie, et al. "Plasma MiR-142 Predicts Major Adverse Cardiovascular Events As an Intermediate Biomarker of Dual Antiplatelet Therapy." Acta Pharmacol Sin 2018.

Cita MLA

Tang, Qian-jie, et al. "Plasma MiR-142 Predicts Major Adverse Cardiovascular Events As an Intermediate Biomarker of Dual Antiplatelet Therapy." Acta Pharmacol Sin 2018.